Stanford University spinout iRhythm, which had raised a total of $115.5m in equity and debt, has gone public in a $107m initial public offering.

Pain assessment technology developer ePat is set to list on the Australian Stock Exchange today, providing an exit to Curtin University.

The advanced electrocardiogram developer, spun out of Stanford University, has set the range for an initial public offering sized at up to $91m.

The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.

Sheffield University spinout Diurnal began trading on Aim, on Christmas eve, raising $44.6m.

Clean hydrogen and graphite production moves closer as Hazer is officially admitted to the Australian Securities Exchange.

The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.